| 000 | 00991cam a22002778a 4500 | ||
|---|---|---|---|
| 001 | vtls000273695 | ||
| 003 | UG-KaMUL | ||
| 005 | 20250612202829.0 | ||
| 010 | _a2005-040638 | ||
| 020 | _a0123693705 (alk. paper) | ||
| 039 |
_a201006010910 _b964 _y201005251021 _z 930 |
||
| 040 |
_aDLC _cDLC _d DLC _d UG-KaMUL |
||
| 082 |
_a174.96606 _2 22 |
||
| 092 | _a174.96606 BIO | ||
| 245 |
_aBioIndustry ethics / _cDavid L. Finegold ... [et al.]. |
||
| 260 |
_aAmsterdam : _bElsevier Academic Press, _c2005. |
||
| 300 |
_axi, 368 p. ; _c23 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 |
_aBiotechnology industries _x Moral and ethical aspects _v Case studie s. |
||
| 650 |
_aPharmaceutical industry _x Moral and ethical aspects _v Case studies . |
||
| 650 |
_aBusiness ethics _x Moral and ethical aspects _v Case studies. |
||
| 700 | _aFinegold, David. | ||
| 942 |
_2ddc _cBK |
||
| 999 |
_c463273 _d463273 |
||